Loading...

APPL Aptus Pharma Ltd Expansion Plans Announcement

pts

PPL

Aptus Pharma Ltd

(APPL)

2025 Announcement

Trading Window Closure

Postal ballot notice and e-...

Capital Increase

Authorized Capital Increase

Trading Window Closure

Authorized Capital Increase

Product Expansion

Award Recognition

Investor Presentation

Regulatory compliance certi...

Geographic Expansion

Product Expansion

Regulatory Compliance

New Product Launch

New Product Launch

Unaudited results

Financial Results

Financial Results Approval

Price Movement Clarification

Compliance Certificate

External Links:

Data:

Aptus Pharma to enter the urology therapy segment with Silodosin, Tamsulosin, and alkalizer products, supported by a large distributor network, signaling growth in a fast-expanding market.

AI Assistant

Aptus Pharma Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.